As a factor contributing to the tumor cell drug resistance, tumor microenvironment (TME) is being paid increasingly attention. However, the drug resistance of malignantly transformed cells in TME has rarely been revealed. This paper is designed to investigate the sensitivity of malignantly transformed cell line (ihDCTC) induced by glioma stem cells (GSCs) in TME to chemotherapeutic drugs.
(1) Establishment of ihDCTC cell line,The bone marrow cells from enhanced green fluorescent protein (EGFP) transgenic nude mice were employed to culture the dendritic cells (DCs) in vitro, which were then co-cultured with red fluorescence protein (RFP) transgenic GSCs (SU3) to obtain ihDCTC (2) Res and Cis were used to intervene in the growth of abovemetioned cell lines in vitro and Res treated in bearing ihDCTC tumor mice, followed by evaluating their drug sensitivity and changes in key signaling proteins via half maximal inhibitory concentration (IC50), tumor mass and immunostaining method.
(1) ihDCTC could express CD11c and CD80 as well as possessed immortalized potential, heteroploid chromosomes and high tumorigenicity in nude mice in vivo. (2) At 24 h, 48 h and 72 h, the IC50 value of ihDCTC treated with Cis was 3.62, 3.25 and 2.10 times higher than that of SU3, while the IC50 value of ihDCTC treated with Res was 0.03, 0.47 and 1.19 times as much as that of SU3; (3) The xenograft mass (g) in vivo in the control, Res, Cis and Res + Cis groups were 1.44 ± 0.19, 0.45 ± 0.12, 0.94 ± 0.80 and 0.68 ± 0.35(x ± s) respectively. The expression levels of IL-6, p-STAT3 and NF-κB proteins in the xenograft tissue were significantly reduced only in the Res treatment group.
In vitro co-culture with GSC can induce the malignant transformation of bone marrow derived dendritic cells, on the one hand, ihDCTC shows higher drug resistance to the traditional chemotherapeutic drug Cis than GSCs, but, on the other hand, appears to be more sensitive to Res than GSCs. Therefore, our findings provide a broader vision not only for the further study on the correlation between TME and tumor drug resistance but also for the exploration of Res anti-cancer value.
Wu J, Wang D, Dai X, et al. Malignant transformation of glioma stromal cells induced by glioma stem cells heterotopicallyinoculated in host liver. Zhonghua Yi Xue Za Zhi. 2014;94(35):2775–80. PubMed
Chen YM, Fei XF, Wang AD, Dai XL, et al. Host glial cell canceration induced by glioma stem cells in GFP/RFP dual fluorescence orthotopicgliomamodels in nude mice. Zhonghua Zhong Liu Za Zhi. 2013 Jan;35(1):5–10. https://doi.org/10.3760/cma.j.issn.0253-3766.2013.01.002. PubMed
Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–22. https://doi.org/10.1016/j.ccr.2012.02.022. CrossRefPubMed
Tariq M, Zhang J, Liang G, Ding L, He Q, Yang B. Macrophage polarization: Anti-cancer Strategies to target Tumor-associated Macrophage in Breast cancer. J Cell Biochem. 2017; https://doi.org/10.1002/jcb.25895.
Dong J, Dai X-L, Lu Z-H, Fei X-F, et al. Incubation and application of transgenic green fluorescent nude mice in visualization studies on glioma tissue remodeling. Chin Med J. 2012;125(24):4349–54. PubMed
Saeidi M, Masoud A, Shakiba Y, et al. Immunomodulatory effects of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells. Iran J Allergy Asthma Immunol. 2013;12(1):37–49. PubMed
Narendra P. Singh, Udai P. Singh, Venkatesh L. Hegde, et al. Resveratrol (trans-3,5,4'-trihydroxystilbene) suppresses EL4 tumor growth by induction of apoptosis involving reciprocal regulation of SIRT1 and NF-κB. Mol Nutr Food Res. 2011;55(8):1207–18. https://doi.org/10.1002/mnfr.201000576.
Sato H, Wu Y, Kato Y, Liu Q, et al. DEC2 expression antagonizes cisplatin-induced apoptosis in human esophageal squamous cell. Carcinoma Mol Med Rep. 2017; https://doi.org/10.3892/mmr.2017.6571.
Wang L, Long L, Wang W, et al. Resveratrol, a potential radiation sensitizer for glioma stem cells both in vitro and in vivo. J Pharmacol Sci. 2015;129(4):216–25. https://doi.org/10.1016/j.jphs.2015.11.001. CrossRefPubMed
Huang S, Chen M, Shen Y, et al. Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. Cancer Lett. 2012;315(2):198–205. https://doi.org/10.1016/j.canlet.2011.10.011. CrossRefPubMed
Chen F, Qin X, Xu G. Reversal of cisplatin resistance in human gastric cancer cells by a wogoninconjugated Pt(IV) prodrug via attenuating casein kinase 2-mediated nuclear factor-κB pathways. Biochem Pharmacol. 2017; https://doi.org/10.1016/j.bcp.2017.03.004.
M J, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol,a natural product derived from grapes. Science. 1997;275(5297):218–20. CrossRef
Wu CF, Yang JY, Wang F, et al. Resveratrol:botanicalorigin,pharmacological activity aIldapplications. Chin J Nat Med. 2013;1l(1):l–15.
Menicacci B, Laurenzana A, Chillà A, et al. Chronic Resveratrol Treatment Inhibits MRC5 Fibroblast SASP-Related Protumoral Effects on Melanoma Cells. J Gerontol A Biol Sci Med Sci. 2017;00(00):1–9. https://doi.org/10.1093/gerona/glw336.
- Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II